PT2694484T
(pt)
|
2011-04-08 |
2018-11-07 |
Janssen Sciences Ireland Uc |
Derivados de pirimidina para o tratamento de infeções virais
|
US10471139B2
(en)
*
|
2013-08-15 |
2019-11-12 |
The University Of Kansas |
Toll-like receptor agonists
|
US20170095573A1
(en)
*
|
2014-06-02 |
2017-04-06 |
Baylor Research Institute |
Methods and compositions for treating allergy and inflammatory diseases
|
KR102492411B1
(ko)
*
|
2014-08-04 |
2023-01-26 |
디비브이 테크놀로지스 (소시에떼 아노님) |
식품 알레르겐에 대한 조성물
|
EA201791346A1
(ru)
*
|
2014-12-16 |
2018-01-31 |
Селджин Корпорейшн |
ТВЕРДЫЕ ФОРМЫ, ВКЛЮЧАЮЩИЕ (1E,4E)-2-АМИНО-N,N-ДИПРОПИЛ-8-(4-(ПИРРОЛИДИН-1-КАРБОНИЛ)ФЕНИЛ)-3H-БЕНЗО[b]-АЗЕПИН-4-КАРБОКСАМИД, ИХ КОМПОЗИЦИИ И ИХ ПРИМЕНЕНИЕ
|
CN107148417B
(zh)
*
|
2014-12-18 |
2020-09-08 |
豪夫迈·罗氏有限公司 |
苯并氮杂*磺酰胺化合物
|
RS56787B1
(sr)
|
2015-03-04 |
2018-04-30 |
Gilead Sciences Inc |
Toll-like receptor koji modulira jedinjenja 4,6-diamino-pirido[3,2-d]pirimidina
|
MA42684A
(fr)
|
2015-08-26 |
2018-07-04 |
Gilead Sciences Inc |
Modulateurs deutérés du récepteur toll
|
EP3349757A1
(en)
|
2015-09-15 |
2018-07-25 |
Gilead Sciences, Inc. |
Modulators of toll-like recptors for the treatment of hiv
|
CN108055842B
(zh)
*
|
2015-09-17 |
2021-06-29 |
豪夫迈·罗氏有限公司 |
亚磺酰基苯基或磺亚胺酰基苯基苯并氮杂䓬
|
TWI814056B
(zh)
|
2015-12-15 |
2023-09-01 |
美商基利科學股份有限公司 |
人類免疫不全病毒中和抗體
|
EP3464245B1
(en)
|
2016-05-23 |
2020-10-14 |
H. Hoffnabb-La Roche Ag |
Benzazepine dicarboxamide compounds with tertiary amide function
|
JP7022702B2
(ja)
|
2016-05-23 |
2022-02-18 |
エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト |
第二級アミド基を有するベンズアゼピンジカルボキサミド化合物
|
BR112018073858A2
(pt)
|
2016-05-27 |
2019-02-26 |
Gilead Sciences, Inc. |
métodos para tratamento de infecções pelo vírus da hepatite b usando inibidores de ns5a, ns5b ou ns3
|
BR102017010009A2
(pt)
|
2016-05-27 |
2017-12-12 |
Gilead Sciences, Inc. |
Compounds for the treatment of hepatitis b virus infection
|
JP7012668B2
(ja)
|
2016-06-12 |
2022-02-14 |
エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト |
ジヒドロピリミジニルベンズアゼピンジカルボキサミド化合物
|
JOP20190024A1
(ar)
|
2016-08-26 |
2019-02-19 |
Gilead Sciences Inc |
مركبات بيروليزين بها استبدال واستخداماتها
|
WO2018045150A1
(en)
|
2016-09-02 |
2018-03-08 |
Gilead Sciences, Inc. |
4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
|
CA3035346A1
(en)
|
2016-09-02 |
2018-03-08 |
Gilead Sciences, Inc. |
Toll like receptor modulator compounds
|
AU2017335205B2
(en)
|
2016-09-29 |
2021-11-04 |
Janssen Sciences Ireland Unlimited Company |
Pyrimidine prodrugs for the treatment of viral infections and further diseases
|
EP3526323B1
(en)
|
2016-10-14 |
2023-03-29 |
Precision Biosciences, Inc. |
Engineered meganucleases specific for recognition sequences in the hepatitis b virus genome
|
TWI784370B
(zh)
|
2017-01-31 |
2022-11-21 |
美商基利科學股份有限公司 |
替諾福韋埃拉酚胺(tenofovir alafenamide)之晶型
|
JOP20180008A1
(ar)
|
2017-02-02 |
2019-01-30 |
Gilead Sciences Inc |
مركبات لعلاج إصابة بعدوى فيروس الالتهاب الكبدي b
|
JOP20180040A1
(ar)
|
2017-04-20 |
2019-01-30 |
Gilead Sciences Inc |
مثبطات pd-1/pd-l1
|
TWI687415B
(zh)
|
2017-08-17 |
2020-03-11 |
美商基利科學股份有限公司 |
Hiv蛋白質膜抑制劑之固體形式
|
AR112412A1
(es)
|
2017-08-17 |
2019-10-23 |
Gilead Sciences Inc |
Formas de sal de colina de un inhibidor de la cápside del vih
|
WO2019040102A1
(en)
|
2017-08-22 |
2019-02-28 |
Gilead Sciences, Inc. |
THERAPEUTIC HETEROCYCLIC COMPOUNDS
|
WO2019084060A1
(en)
|
2017-10-24 |
2019-05-02 |
Silverback Therapeutics, Inc. |
CONJUGATES AND METHODS OF USE FOR THE SELECTIVE DELIVERY OF IMMUNOMODULATORY AGENTS
|
CN111601822A
(zh)
|
2017-12-15 |
2020-08-28 |
希沃尔拜克治疗公司 |
用于治疗肝炎的抗体构建体-药物缀合物
|
WO2019123339A1
(en)
|
2017-12-20 |
2019-06-27 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3' cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
CA3084569A1
(en)
|
2017-12-20 |
2019-06-27 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3' cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
KR102586510B1
(ko)
|
2018-02-13 |
2023-10-12 |
길리애드 사이언시즈, 인코포레이티드 |
Pd-1/pd-l1 억제제
|
EP3752495B1
(en)
|
2018-02-15 |
2023-07-19 |
Gilead Sciences, Inc. |
Pyridine derivatives and their use for treating hiv infection
|
CN112055712B
(zh)
|
2018-02-16 |
2023-07-14 |
吉利德科学公司 |
用于制备可用于治疗逆转录病毒科病毒感染的治疗性化合物的方法和中间体
|
ES2962605T3
(es)
|
2018-02-26 |
2024-03-20 |
Gilead Sciences Inc |
Compuestos de pirrolizina sustituidos como inhibidores de la replicación del VHB
|
TW201945003A
(zh)
|
2018-03-01 |
2019-12-01 |
愛爾蘭商健生科學愛爾蘭無限公司 |
2,4-二胺基喹唑啉衍生物及其醫學用途
|
US10870691B2
(en)
|
2018-04-05 |
2020-12-22 |
Gilead Sciences, Inc. |
Antibodies and fragments thereof that bind hepatitis B virus protein X
|
TWI833744B
(zh)
|
2018-04-06 |
2024-03-01 |
捷克科學院有機化學與生物化學研究所 |
3'3'-環二核苷酸
|
TWI818007B
(zh)
|
2018-04-06 |
2023-10-11 |
捷克科學院有機化學與生物化學研究所 |
2'3'-環二核苷酸
|
TW202005654A
(zh)
|
2018-04-06 |
2020-02-01 |
捷克科學院有機化學與生物化學研究所 |
2,2,─環二核苷酸
|
TW201945388A
(zh)
|
2018-04-12 |
2019-12-01 |
美商精密生物科學公司 |
對b型肝炎病毒基因體中之識別序列具有特異性之最佳化之經工程化巨核酸酶
|
WO2019204609A1
(en)
|
2018-04-19 |
2019-10-24 |
Gilead Sciences, Inc. |
Pd-1/pd-l1 inhibitors
|
US20190359645A1
(en)
|
2018-05-03 |
2019-11-28 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3'-cyclic dinucleotides comprising carbocyclic nucleotide
|
DE102018113509A1
(de)
|
2018-06-06 |
2019-12-12 |
Philipps-Universität Marburg |
Mikroemulsion zur dermalen Hyposensibilisierung mit Allergenen
|
SG11202012043RA
(en)
|
2018-07-03 |
2021-01-28 |
Gilead Sciences Inc |
Antibodies that target hiv gp120 and methods of use
|
CA3103987C
(en)
|
2018-07-06 |
2023-08-01 |
Gilead Sciences, Inc. |
Therapeutic heterocyclic compounds
|
WO2020010223A1
(en)
|
2018-07-06 |
2020-01-09 |
Gilead Sciences, Inc. |
Therapeutic heterocyclic compounds
|
PT3820572T
(pt)
|
2018-07-13 |
2023-11-10 |
Gilead Sciences Inc |
Inibidores pd-1/pd-l1
|
TWI814350B
(zh)
|
2018-07-16 |
2023-09-01 |
美商基利科學股份有限公司 |
用於治療hiv之蛋白殼抑制劑
|
WO2020028097A1
(en)
|
2018-08-01 |
2020-02-06 |
Gilead Sciences, Inc. |
Solid forms of (r)-11-(methoxymethyl)-12-(3-methoxypropoxy)-3,3-dimethyl-8-0x0-2,3,8,13b-tetrahydro-1h-pyrido[2,1-a]pyrrolo[1,2-c] phthalazine-7-c arboxylic acid
|
CN113164618A
(zh)
|
2018-09-12 |
2021-07-23 |
希沃尔拜克治疗公司 |
用免疫刺激性缀合物治疗疾病的方法和组合物
|
WO2020072656A1
(en)
|
2018-10-03 |
2020-04-09 |
Gilead Sciences, Inc. |
Imidozopyrimidine derivatives
|
JP7158577B2
(ja)
|
2018-10-24 |
2022-10-21 |
ギリアード サイエンシーズ, インコーポレイテッド |
Pd-1/pd-l1阻害剤
|
FI3873903T3
(fi)
|
2018-10-31 |
2024-03-26 |
Gilead Sciences Inc |
Substituoituja 6-azabentsiimidatsoliyhdisteitä HPK1-inhibiittoreina
|
WO2020092528A1
(en)
|
2018-10-31 |
2020-05-07 |
Gilead Sciences, Inc. |
Substituted 6-azabenzimidazole compounds having hpk1 inhibitory activity
|
WO2020176510A1
(en)
|
2019-02-25 |
2020-09-03 |
Gilead Sciences, Inc. |
Protein kinase c agonists
|
WO2020176505A1
(en)
|
2019-02-25 |
2020-09-03 |
Gilead Sciences, Inc. |
Protein kinase c agonists
|
KR20210137518A
(ko)
|
2019-03-07 |
2021-11-17 |
인스티튜트 오브 오가닉 케미스트리 앤드 바이오케미스트리 에이에스 씨알 브이.브이.아이. |
3'3'-사이클릭 다이뉴클레오티드 및 이의 프로드럭
|
EP3935065A1
(en)
|
2019-03-07 |
2022-01-12 |
Institute of Organic Chemistry and Biochemistry ASCR, V.V.I. |
3'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator
|
CA3129022C
(en)
|
2019-03-07 |
2023-08-01 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3'-cyclic dinucleotides and prodrugs thereof
|
TW202210480A
(zh)
|
2019-04-17 |
2022-03-16 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
TWI751517B
(zh)
|
2019-04-17 |
2022-01-01 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
TW202231277A
(zh)
|
2019-05-21 |
2022-08-16 |
美商基利科學股份有限公司 |
鑑別對使用gp120 v3聚醣導向之抗體的治療敏感之hiv病患的方法
|
EP3972695A1
(en)
|
2019-05-23 |
2022-03-30 |
Gilead Sciences, Inc. |
Substituted exo-methylene-oxindoles which are hpk1/map4k1 inhibitors
|
CN114008029A
(zh)
|
2019-06-18 |
2022-02-01 |
爱尔兰詹森科学公司 |
用于治疗病毒感染和另外的疾病的喹唑啉前药
|
WO2020255019A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and a quinazoline derivative
|
US20220305115A1
(en)
|
2019-06-18 |
2022-09-29 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and pyridopyrimidine derivatives
|
WO2020257407A1
(en)
|
2019-06-19 |
2020-12-24 |
Silverback Therapeutics, Inc. |
Anti-mesothelin antibodies and immunoconjugates thereof
|
CA3142513A1
(en)
|
2019-06-25 |
2020-12-30 |
Gilead Sciences, Inc. |
Flt3l-fc fusion proteins and methods of use
|
JP7454645B2
(ja)
|
2019-07-16 |
2024-03-22 |
ギリアード サイエンシーズ, インコーポレイテッド |
Hivワクチン並びにその作製方法及び使用方法
|
US20220257619A1
(en)
|
2019-07-18 |
2022-08-18 |
Gilead Sciences, Inc. |
Long-acting formulations of tenofovir alafenamide
|
KR20220058555A
(ko)
|
2019-08-15 |
2022-05-09 |
실버백 테라퓨틱스, 인크. |
벤즈아제핀 접합체의 제형 및 이의 용도
|
US20220296619A1
(en)
|
2019-08-19 |
2022-09-22 |
Gilead Sciences, Inc. |
Pharmaceutical formulations of tenofovir alafenamide
|
AU2020357502A1
(en)
|
2019-09-30 |
2022-05-19 |
Gilead Sciences, Inc. |
HBV vaccines and methods treating HBV
|
AU2020358726A1
(en)
|
2019-10-01 |
2022-04-07 |
Silverback Therapeutics, Inc. |
Combination therapy with immune stimulatory conjugates
|
CN118178645A
(zh)
|
2019-10-18 |
2024-06-14 |
四十七公司 |
用于治疗骨髓增生异常综合征和急性髓系白血病的联合疗法
|
JP2022552748A
(ja)
|
2019-10-31 |
2022-12-19 |
フォーティ セブン, インコーポレイテッド |
抗cd47及び抗cd20による血液癌の治療
|
TWI778443B
(zh)
|
2019-11-12 |
2022-09-21 |
美商基利科學股份有限公司 |
Mcl1抑制劑
|
CN114727999A
(zh)
|
2019-11-26 |
2022-07-08 |
吉利德科学公司 |
用于预防hiv的衣壳抑制剂
|
EP4069729A1
(en)
|
2019-12-06 |
2022-10-12 |
Precision BioSciences, Inc. |
Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome
|
KR20220131918A
(ko)
|
2019-12-24 |
2022-09-29 |
카나 바이오사이언스, 인코포레이션 |
다이아실글리세롤 키나제 조절 화합물
|
TWI832035B
(zh)
|
2020-02-14 |
2024-02-11 |
美商基利科學股份有限公司 |
結合ccr8之抗體及融合蛋白及其用途
|
US11179473B2
(en)
|
2020-02-21 |
2021-11-23 |
Silverback Therapeutics, Inc. |
Nectin-4 antibody conjugates and uses thereof
|
EP4121437A1
(en)
|
2020-03-20 |
2023-01-25 |
Gilead Sciences, Inc. |
Prodrugs of 4'-c-substituted-2-halo-2'-deoxyadenosine nucleosides and methods of making and using the same
|
WO2021222522A1
(en)
|
2020-05-01 |
2021-11-04 |
Gilead Sciences, Inc. |
Cd73 inhibiting 2,4-dioxopyrimidine compounds
|
WO2021236944A1
(en)
|
2020-05-21 |
2021-11-25 |
Gilead Sciences, Inc. |
Pharmaceutical compositions comprising bictegravir
|
CN115996925A
(zh)
|
2020-06-25 |
2023-04-21 |
吉利德科学公司 |
用于治疗hiv的衣壳抑制剂
|
EP4175673A1
(en)
|
2020-07-01 |
2023-05-10 |
ARS Pharmaceuticals Inc. |
Anti-asgr1 antibody conjugates and uses thereof
|
KR20230048118A
(ko)
|
2020-08-07 |
2023-04-10 |
길리애드 사이언시즈, 인코포레이티드 |
포스폰아미드 뉴클레오티드 유사체의 프로드러그 및 이의 약학적 용도
|
TW202406932A
(zh)
|
2020-10-22 |
2024-02-16 |
美商基利科學股份有限公司 |
介白素2-Fc融合蛋白及使用方法
|
US20220144923A1
(en)
|
2020-11-11 |
2022-05-12 |
Gilead Sciences, Inc. |
METHODS OF IDENTIFYING HIV PATIENTS SENSITIVE TO THERAPY WITH gp120 CD4 BINDING SITE-DIRECTED ANTIBODIES
|
WO2022217022A1
(en)
|
2021-04-10 |
2022-10-13 |
Profoundbio Us Co. |
Folr1 binding agents, conjugates thereof and methods of using the same
|
TW202302145A
(zh)
|
2021-04-14 |
2023-01-16 |
美商基利科學股份有限公司 |
CD47/SIRPα結合及NEDD8活化酶E1調節次單元之共抑制以用於治療癌症
|
TW202308699A
(zh)
|
2021-04-23 |
2023-03-01 |
美商普方生物製藥美國公司 |
Cd70結合劑、其結合物及其使用方法
|
AU2022274607A1
(en)
|
2021-05-13 |
2023-11-16 |
Gilead Sciences, Inc. |
COMBINATION OF A TLR8 MODULATING COMPOUND AND ANTI-HBV siRNA THERAPEUTICS
|
WO2022245671A1
(en)
|
2021-05-18 |
2022-11-24 |
Gilead Sciences, Inc. |
Methods of using flt3l-fc fusion proteins
|
EP4359413A1
(en)
|
2021-06-23 |
2024-05-01 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
CA3222439A1
(en)
|
2021-06-23 |
2022-12-29 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
CN117480155A
(zh)
|
2021-06-23 |
2024-01-30 |
吉利德科学公司 |
二酰基甘油激酶调节化合物
|
AU2022299051A1
(en)
|
2021-06-23 |
2023-12-07 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
TW202320857A
(zh)
|
2021-07-06 |
2023-06-01 |
美商普方生物製藥美國公司 |
連接子、藥物連接子及其結合物及其使用方法
|
CA3234909A1
(en)
|
2021-10-28 |
2023-05-04 |
Gilead Sciences, Inc. |
Pyridizin-3(2h)-one derivatives
|
AU2022376954A1
(en)
|
2021-10-29 |
2024-05-02 |
Gilead Sciences, Inc. |
Cd73 compounds
|
WO2023102523A1
(en)
|
2021-12-03 |
2023-06-08 |
Gilead Sciences, Inc. |
Therapeutic compounds for hiv virus infection
|
WO2023102529A1
(en)
|
2021-12-03 |
2023-06-08 |
Gilead Sciences, Inc. |
Therapeutic compounds for hiv virus infection
|
AU2022401696A1
(en)
|
2021-12-03 |
2024-05-09 |
Gilead Sciences, Inc. |
Therapeutic compounds for hiv virus infection
|
US20230220106A1
(en)
|
2021-12-08 |
2023-07-13 |
Dragonfly Therapeutics, Inc. |
Antibodies targeting 5t4 and uses thereof
|
WO2023107956A1
(en)
|
2021-12-08 |
2023-06-15 |
Dragonfly Therapeutics, Inc. |
Proteins binding nkg2d, cd16 and 5t4
|
US20240124412A1
(en)
|
2021-12-22 |
2024-04-18 |
Gilead Sciences, Inc. |
Ikaros zinc finger family degraders and uses thereof
|
WO2023122615A1
(en)
|
2021-12-22 |
2023-06-29 |
Gilead Sciences, Inc. |
Ikaros zinc finger family degraders and uses thereof
|
TW202340168A
(zh)
|
2022-01-28 |
2023-10-16 |
美商基利科學股份有限公司 |
Parp7抑制劑
|
EP4245756A1
(en)
|
2022-03-17 |
2023-09-20 |
Gilead Sciences, Inc. |
Ikaros zinc finger family degraders and uses thereof
|
US20230355796A1
(en)
|
2022-03-24 |
2023-11-09 |
Gilead Sciences, Inc. |
Combination therapy for treating trop-2 expressing cancers
|
TW202345901A
(zh)
|
2022-04-05 |
2023-12-01 |
美商基利科學股份有限公司 |
用於治療結腸直腸癌之組合療法
|
TW202400172A
(zh)
|
2022-04-06 |
2024-01-01 |
美商基利科學股份有限公司 |
橋聯三環胺甲醯基吡啶酮化合物及其用途
|
TW202400138A
(zh)
|
2022-04-21 |
2024-01-01 |
美商基利科學股份有限公司 |
Kras g12d調節化合物
|
WO2024006929A1
(en)
|
2022-07-01 |
2024-01-04 |
Gilead Sciences, Inc. |
Cd73 compounds
|
US20240034724A1
(en)
|
2022-07-01 |
2024-02-01 |
Gilead Sciences, Inc. |
Therapeutic compounds useful for the prophylactic or therapeutic treatment of an hiv virus infection
|
WO2024015741A1
(en)
|
2022-07-12 |
2024-01-18 |
Gilead Sciences, Inc. |
Hiv immunogenic polypeptides and vaccines and uses thereof
|
US20240083984A1
(en)
|
2022-08-26 |
2024-03-14 |
Gilead Sciences, Inc. |
Dosing and scheduling regimen for broadly neutralizing antibodies
|
WO2024064668A1
(en)
|
2022-09-21 |
2024-03-28 |
Gilead Sciences, Inc. |
FOCAL IONIZING RADIATION AND CD47/SIRPα DISRUPTION ANTICANCER COMBINATION THERAPY
|
WO2024076915A1
(en)
|
2022-10-04 |
2024-04-11 |
Gilead Sciences, Inc. |
4'-thionucleoside analogues and their pharmaceutical use
|